194 related articles for article (PubMed ID: 28727133)
1. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome?
Başbuğ D; Başbuğ A; Gülerman C
Ginekol Pol; 2017; 88(6):325-330. PubMed ID: 28727133
[TBL] [Abstract][Full Text] [Related]
2. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
[TBL] [Abstract][Full Text] [Related]
3. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
4. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Simpson JL; Palomaki GE; Mercer B; Haddow JE; Andersen R; Sibai B; Elias S
Am J Obstet Gynecol; 1995 Dec; 173(6):1742-8. PubMed ID: 8610755
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening.
Cho S; Durfee KK; Keel BA; Parks LH
J Perinat Med; 1997; 25(6):476-83. PubMed ID: 9494919
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
7. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
8. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
9. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
[TBL] [Abstract][Full Text] [Related]
10. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
[TBL] [Abstract][Full Text] [Related]
12. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
[TBL] [Abstract][Full Text] [Related]
13. Very low second-trimester maternal serum alpha-fetoprotein: Association with high birth weight.
Baschat AA; Harman CR; Farid G; Chodirker BN; Evans JA
Obstet Gynecol; 2002 Apr; 99(4):531-6. PubMed ID: 12039105
[TBL] [Abstract][Full Text] [Related]
14. The effects on fetal development of high alpha-fetoprotein and maternal smoking.
Heinonen S; Ryynänen M; Kirkinen P
Am J Public Health; 1999 Apr; 89(4):561-3. PubMed ID: 10191802
[TBL] [Abstract][Full Text] [Related]
15. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels.
Puntachai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
Arch Gynecol Obstet; 2015 Jul; 292(1):81-5. PubMed ID: 25547063
[TBL] [Abstract][Full Text] [Related]
16. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Huerta-Enochian G; Katz V; Erfurth S
Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
[TBL] [Abstract][Full Text] [Related]
17. Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery.
Weiner CP; Grant SS; Williamson RA
Am J Perinatol; 1991 Jul; 8(4):263-8. PubMed ID: 1720619
[TBL] [Abstract][Full Text] [Related]
18. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
19. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
